Blue-light cystoscopy and narrow-band imaging in bladder cancer management

Despite the high resolution of modern imaging technology including computed tomography and magnetic resonance imaging, cystoscopy remains the gold standard method for detecting bladder cancer. Cystoscopy is conventionally conducted with white light visualization, and the pitfalls of white light cyst...

Full description

Saved in:
Bibliographic Details
Published inFormosan journal of surgery : the official publication of the Surgical Association ... [et al.] Vol. 52; no. 5; pp. 155 - 160
Main Authors Zang, Zhijiang, Wu, Qinghui, Chiong, Edmund
Format Journal Article
LanguageEnglish
Published Wolters Kluwer - Medknow Publications 01.09.2019
Wolters Kluwer Health/LWW
Subjects
bladder cancer
blue-light cystoscopy
narrow-band imaging
Bladder cancer
blue-light cystoscopy
narrow-band imaging
Online AccessGet full text

Cover

More Information
Summary:Despite the high resolution of modern imaging technology including computed tomography and magnetic resonance imaging, cystoscopy remains the gold standard method for detecting bladder cancer. Cystoscopy is conventionally conducted with white light visualization, and the pitfalls of white light cystoscopy are well-recognized. Novel technologies to enhance visualization of bladder lesion have emerged during the past 20 years. Among them, blue-light cystoscopy (BLC) and narrow-band imaging (NBI) are the most promising and well-studied. Many clinical trials have suggested the benefit of these two technologies. In this review, we aim to summarize the data, evidence, and current role of BLC and NBI in clinical practice.
ISSN:1682-606X
DOI:10.4103/fjs.fjs_133_18